T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
XYZ
Block, Inc.
XYZ
|
+$2.23B |
| 2 |
Carvana
CVNA
|
+$1.65B |
| 3 |
Microsoft
MSFT
|
+$1.46B |
| 4 |
Affirm
AFRM
|
+$1.2B |
| 5 |
Walt Disney
DIS
|
+$1.18B |
Top Sells
| 1 |
Visa
V
|
+$2.51B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.93B |
| 4 |
Salesforce
CRM
|
+$1.88B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.52B |
Sector Composition
| 1 | Technology | 25.2% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.81% |
| 5 | Financials | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
LPL Financial
LPLA
$27.8B
| $97.4M | 0.01% |
621,181
+16,746
| +3% | +$2.63M |
|
777
Medpace
MEDP
$14B
| $97.1M | 0.01% |
513,229
-189,782
| -27% | -$35.9M |
|
|
HNGR
778
DELISTED
Hanger Inc.
HNGR
| $97.1M | 0.01% |
4,419,513
+26,243
| +0.6% | +$576K |
|
779
Emerson Electric
EMR
$77.4B
| $96.8M | 0.01% |
1,027,953
-296,126
| -22% | -$27.9M |
|
780
ResMed
RMD
$40.2B
| $96.6M | 0.01% |
366,591
+2,042
| +0.6% | +$538K |
|
781
Novavax
NVAX
$1.34B
| $96.6M | 0.01% |
465,919
+76,195
| +20% | +$15.8M |
|
782
Evergy
EVRG
$16.6B
| $96.4M | 0.01% |
1,550,378
-1,636,377
| -51% | -$102M |
|
|
IAA
783
DELISTED
IAA, Inc. Common Stock
IAA
| $96M | 0.01% |
1,759,560
+32,257
| +2% | +$1.76M |
|
|
RDUS
784
DELISTED
Radius Health, Inc.
RDUS
| $95.5M | 0.01% |
7,691,671
-278,505
| -3% | -$3.46M |
|
|
PARA
785
DELISTED
Paramount Global Class B
PARA
| $95.4M | 0.01% |
2,415,775
-349,192
| -13% | -$13.8M |
|
|
CVET
786
DELISTED
Covetrus, Inc. Common Stock
CVET
| $95.3M | 0.01% |
5,255,977
-1,131,339
| -18% | -$20.5M |
|
787
Eaton
ETN
$140B
| $94.7M | 0.01% |
634,031
-9,435
| -1% | -$1.41M |
|
|
BFS
788
Saul Centers
BFS
$789M
| $94.4M | 0.01% |
2,142,386
+9,438
| +0.4% | +$416K |
|
789
BioMarin Pharmaceuticals
BMRN
$10.7B
| $93.9M | 0.01% |
1,214,887
-445,429
| -27% | -$34.4M |
|
790
AMN Healthcare
AMN
$727M
| $93.7M | 0.01% |
816,535
-33,562
| -4% | -$3.85M |
|
|
HZNP
791
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $93.6M | 0.01% |
854,191
-55,275
| -6% | -$6.05M |
|
792
Timken Company
TKR
$5.51B
| $93.4M | 0.01% |
1,428,355
-45,657
| -3% | -$2.99M |
|
793
Tidewater
TDW
$2.94B
| $93.4M | 0.01% |
7,743,845
+453,131
| +6% | +$5.46M |
|
794
IQVIA
IQV
$32.4B
| $91.8M | 0.01% |
383,295
-11,792
| -3% | -$2.82M |
|
795
Unifirst Corp
UNF
$3.27B
| $91.7M | 0.01% |
431,440
-40,135
| -9% | -$8.53M |
|
796
Charles River Laboratories
CRL
$7.86B
| $91.5M | 0.01% |
221,784
-65,081
| -23% | -$26.9M |
|
797
Trane Technologies
TT
$92.3B
| $90.7M | 0.01% |
525,466
-14,619
| -3% | -$2.52M |
|
798
Dime Community Bancshares
DCOM
$1.36B
| $90.7M | 0.01% |
2,776,959
-699,214
| -20% | -$22.8M |
|
799
Takeda Pharmaceutical
TAK
$48.4B
| $90.4M | 0.01% |
5,518,932
+132,629
| +2% | +$2.17M |
|
800
Edison International
EIX
$21.6B
| $90.2M | 0.01% |
1,625,341
-3,620,493
| -69% | -$201M |
|